PGY2 Oncology Specialty Residency

The ASHP-accredited PGY2 Oncology Specialty Residency at City of Hope is a structured one-year program designed to provide the resident with a solid foundation of core experiences in hematology, oncology and stem cell transplant. The program provides broad-based rotational experiences to help develop and refine the resident’s clinical skills in the pharmaceutical management of cancer patients. A resident completing the PGY2 Oncology Residency at City of Hope will be a highly qualified independent practitioner able to provide and be responsible for drug therapy outcomes for individualized patients as an integral member of the multidisciplinary team.
The City of Hope PGY2 Oncology Specialty Residency starts during the first week of July and accepts one candidate each year.
During the PGY2 Oncology Specialty Residency, the resident will:
  • Develop expertise, knowledge and skills in oncology therapeutics
  • Be responsible for achieving optimal drug therapy outcomes as a member of the multidisciplinary health care team
  • Skillfully educate other health care professionals and patients on drug-related topics
  • Exercise leadership in improving the safety of the medication-use system
  • Strengthen verbal and written communication skills by leading discussions, presenting lectures and writing a research manuscript
  • Demonstrate professional maturity by following a personal philosophy of practice, monitoring his or her own performance, and exhibiting commitment to self-improvement and advancement of the profession as a whole
Residency activities include:
  • Completion of an IRB-approved residency research project
  • Other clinical and administrative projects chosen with the program director’s input
  • Attendance at educational meetings and conferences
  • ACLS and BCLS certification or recertification
  • Participation in hospital pharmacy administrative committees
  • Clinical rotations through a wide variety of hematology/oncology inpatient and ambulatory care practice arenas, including stem cell transplantation, clinical nutrition, critical care and investigational drug services
  • Educational activities for staff pharmacists, PGY1 pharmacy residents and pharmacy students

 Qualifications for application:
  • Graduation from an ACPE-accredited school of pharmacy with a Pharm.D. degree
  • Completion of a PGY1 pharmacy residency
  • Pharmacy licensure in the state of California by September 1 in the year in which the candidate will start the PGY2 residency
  • Candidate should be comfortable and competent in clinical situations, self-motivated, independent and self-directed


For Further Information:

Program Director
Sepideh Shayani, Pharm.D., BCOP
[email protected]

Pharmacy Director
Carl Kildoo, Pharm.D.
[email protected]